Kaiser Health News consumer columnist Michelle Andrews writes: "People who need expensive drugs to treat serious medical conditions often rely on drug manufacturers’ assistance programs to help afford their medications. But it’s uncertain whether such programs are permitted to aid people who buy health insurance on the marketplaces established by the federal health law. With open enrollment ending in less than two months, federal rules remain unclear, leaving patients, advocates and drug programs in limbo. They're concerned about how recent guidance recommending that third parties refrain from making payments to help patients with cost sharing or premiums may affect these programs" (Andrews, 2/4). Read the column.
This is part of Kaiser Health News' Daily Report - a summary of health policy coverage from major news organizations. The full summary of the day's news can be found here and you can sign up for e-mail subscriptions to the Daily Report here. In addition, our staff of reporters and correspondents file original stories each day, which you can find on our home page.